drugset / Trial / NCT06392711

Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia

NCT06392711

Phase 1 Recruiting 36 enrolled University of Wisconsin, Madison
Non-randomizedSequentialOpen-labelTreatment

Summary

The goal of this clinical trial is to evaluate the safety and tolerability of injecting certain cells produced in bone marrow called mesenchymal stromal cells (MSCs) into salivary glands. The main question it aims to answer is whether injection of MSCs into salivary glands results in any improvement in dry mouth. Participants will: * have bone marrow collected using a needle * undergo a salivary gland ultrasound * complete questionnaires * receive an injection of the bone marrow cells into a salivary gland

Timeline

Start
2024-10-04
Primary completion
2028-11
Completion
2028-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator mesenchymal stem cells Cell therapy 1e+07 cells Other
Comparator mesenchymal stem cells Cell therapy 2e+07 cells Other